Global Market for Cancer Profiling Technologies to Reach Nearly $54.8 Billion

The global healthcare industry is seeing new developments, improved point-of-care diagnostics, cost-effective treatment modalities, and advances in personalized medicine, which not only offer efficient early diagnosis, but also allow for the treatment of cancer conditions in order to reduce the healthcare cost and disease burden. Cancer/tumor profiling is one such technology with the potential to revolutionize cancer diagnostics and therapeutics in the healthcare industry. These applications offer tremendous opportunities for key players in this market.

BCC Research provides an in-depth analysis of the global market for cancer profiling technologies through its report, Cancer Profiling and Pathways: Technologies and Global Markets. According to the report, this market reached $26.1 billion in 2012 and nearly $30.1 billion in 2013. BCC Research projects the market to grow to nearly $54.8 billion by 2018, and register a five-year compound annual growth rate of 12.8% from 2013 to 2018.

Use this report for, but not limited to, the following reasons:

• Gain an overview of the global market for cancer profiling and biomarker studies

• Analyze global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018

• Evaluate products in this market, cancer markets in newly emerging tools, diagnostics and therapeutics, and their impacts on the market

• Examine evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering the molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers

• Identify important cancer profiling techniques, market share by type of products on the market and market share by company, as well as types of cancers and biomarkers

• Assess coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials, and currently marketed and clinical-stage development products

• Review comprehensive company profiles of key players in the market

  
  

• 
  

• Click here to order your copy of this report (or any of its chapters) or to download the report overview.

  You may be also interested in our following related reports:

• BIO071B Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

• BIO061C Biomarkers: The Expanding Global Market

  Please email us at reports@bccresearch.org if you have any questions pertaining to this report.

  
  Paul DeAngelis
  BCC Research LLC
  49 Walnut Park, Building 2
  Wellesley, MA 02481, USA
  (+1) 781-325-8350